Survival rate and the determinants of progression from HIV to AIDS and from AIDS to the death in Iran: 1987 to 2016

被引:0
|
作者
Mohammad Mirzaei [1 ]
Maryam Farhadian [2 ]
Jalal Poorolajal [3 ]
Parvin Afsar Kazerooni [4 ]
Katayoun Tayeri [5 ]
Younes Mohammadi [6 ]
机构
[1] Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences
[2] Research Center for Health Sciences, Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences
[3] Modeling of Noncommunicable Diseases Research Center, Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences
[4] HIV/AIDS Research Center, Shiraz University of Medical Sciences
[5] Iranian Research Center of HIV&AIDS, Tehran University of Medical Sciences
[6] Social Determinants of Health Research Center, School of Public Health, Hamadan University of Medical Sciences
关键词
HIV/AIDS; Prognostic factor; Survival time; Tuberculosis; Cohort study;
D O I
暂无
中图分类号
R512.91 [获得性免疫缺陷综合征(AIDS艾滋病)];
学科分类号
100401 ;
摘要
Objective: To examine the prognostic factors of progression from HIV to AIDS and AIDS to the death in people living with HIV/AIDS in Iran.Methods: In this registry-based retrospective cohort study, we recruited 28 873 HIV-infected people from 158 Behavioral Diseases Counseling Centers of Iran.Two outcomes of interest included survival rates from HIV diagnosis to AIDS and from AIDS to the death.We used Kaplan-Meier and Cox regression model to investigate survival rate and factors affecting on survival controlling effect of confounding factors.Results: The one, three, five, and ten-year survival rate from HIV to AIDS were 85%, 73%, 61% and 32%, and for AIDS to death were 90%, 81%, 74% and 55%, respectively.Multivariate Cox regression analysis indicated that the risk of progression from AIDS phase toward death in individuals with CD4 less than 200/mm;, infected with tuberculosis(TB) and not treated by antiretroviral therapy(ART) was 2.17(95% CI: 1.62-2.90), 1.49(95% CI: 1.01-2.20) and 4.88(95% CI: 3.42-6.96) times higher respectively.The risk of progression to AIDS in patients with baseline CD4 less than 200/mm;was 2.32(95% CI: 2.14, 2.51) times higher than patients with CD4 > 200/mm;(P=0.001).On the other hand, tuberculosis increases the risk of death by 49.0%(P=0.04).The hazard ratio of death in patients who did not receive ART was 4.88(95% CI: 3.42, 6.96) times higher than patients who received ART(P<0.001).Conclusion: The early detection of HIV, the screening and treatment of TB and receiving the ART improve the survival of HIV/AIDS patients significantly, and prevent the transmission of HIV to other people.
引用
收藏
页码:72 / 78
页数:7
相关论文
共 50 条
  • [1] Survival rate and the determinants of progression from HIV to AIDS and from AIDS to the death in Iran: 1987 to 2016
    Mirzaei, Mohammad
    Farhadian, Maryam
    Poorolajal, Jalal
    Kazerooni, Parvin Afsar
    Tayeri, Katayoun
    Mohammadi, Younes
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2019, 12 (02) : 72 - 78
  • [2] Identifying risk factors for late HIV diagnosis and survival analysis of people living with HIV/AIDS in Iran (1987–2016)
    Younes Mohammadi
    Mohammad Mirzaei
    Nasrin Shirmohammadi-Khorram
    Maryam Farhadian
    [J]. BMC Infectious Diseases, 21
  • [3] The profile of health care utilization among HIV/AIDS patients in Iran from 1987 to 2016: A nationwide study
    Mirmoghadam, Zahra
    Karami, Manoochehr
    Mohammadi, Younes
    Mirzaei, Mohammad
    [J]. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2019, 7 (03): : 429 - 434
  • [4] Identifying risk factors for late HIV diagnosis and survival analysis of people living with HIV/AIDS in Iran (1987-2016)
    Mohammadi, Younes
    Mirzaei, Mohammad
    Shirmohammadi-Khorram, Nasrin
    Farhadian, Maryam
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [5] Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001
    Hall, H. Irene
    McDavid, Kathleen
    Ling, Qiang
    Sloggett, Andrew
    [J]. ANNALS OF EPIDEMIOLOGY, 2006, 16 (11) : 824 - 833
  • [6] Dynamics of HIV/AIDS in Turkey from 1985 to 2016
    Sayan M.
    Hınçal E.
    Şanlıdağ T.
    Kaymakamzade B.
    Sa’ad F.T.
    Baba I.A.
    [J]. Quality & Quantity, 2018, 52 (Suppl 1) : 711 - 723
  • [7] Predicting death from HIV/AIDS: A case-control study from Florida public HIV/AIDS clinics
    Lieb, S
    Brooks, RG
    Hopkins, RS
    Thompson, D
    Crockett, LK
    Liberti, T
    Jani, AA
    Nadler, JP
    Virkud, VM
    West, KC
    McLaughlin, G
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (03) : 351 - 358
  • [8] Determinants of progression to AIDS in HIV-infected individuals: An update from the Italian Seroconversion Study
    Rezza, G
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 : S13 - S16
  • [9] Determinants and economic burden of HIV/AIDS in Iran: a prospective study
    Tahmineh Reshadat-Hajiabad
    Alireza Khajavi
    Ali Mohammad Hosseinpour
    Amin Bojdy
    Amir Hashemi-Meshkini
    Mehdi Varmaghani
    [J]. BMC Health Services Research, 23
  • [10] Determinants and economic burden of HIV/AIDS in Iran: a prospective study
    Reshadat-Hajiabad, Tahmineh
    Khajavi, Alireza
    Hosseinpour, Ali Mohammad
    Bojdy, Amin
    Hashemi-Meshkini, Amir
    Varmaghani, Mehdi
    [J]. BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)